A Study to Evaluate the Safety and Effectiveness of WF10 Given to Patients With Late-Stage HIV Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is safe and effective to give WF10 to adults with
late-stage HIV disease. WF10 is suspected to help the immune system fight infection and slow
HIV disease progression.